Finance

Lists
Why is B8FK down 2.96%?
Dive Deeper
B8FK:FRA
Biofrontera AG
€2.95
-2.96%
(-0.090) 1D
Oct 9, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for B8FK...
Open
€2.95
High
€2.95
Low
€2.95
Mkt. cap
17.99M
Avg. vol.
171.00
Volume
0.00
P/E ratio
3.40
52-wk high
€4.80
52-wk low
€2.18
EPS
€0.87
No. of employees
62
Open
€2.95
High
€2.95
Low
€2.95
Mkt. cap
17.99M
Avg. vol.
171.00
Volume
0.00
P/E ratio
3.40
52-wk high
€4.80
52-wk low
€2.18
EPS
€0.87
No. of employees
62
News stories
From web sources and news partners
About Biofrontera AG
CEO-
Employees62
Founded1997
Headquarters-
SectorPharmaceutical industry
Websitebiofrontera.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.55M
-
3.71M
5.32M
Cost of goods sold
1.15M
-
709.00K
1.01M
Cost of revenue
1.15M
-
709.00K
1.01M
Research and development expenses
1.20M
-
539.00K
601.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.20M
-
2.46M
2.28M
Operating expense
3.40M
-
3.00M
2.89M
Total operating expenses
4.56M
-
3.70M
3.89M
Operating income
-1.00M
-
9.00K
1.43M
Other non operating income
540.00K
-
38.00K
37.00K
EBT including unusual items
-369.00K
-
41.00K
1.47M
EBT excluding unusual items
-369.00K
-
41.00K
1.47M
Income tax expense
1.00K
-
-
4.00K
Effective tax rate
-0.27%
-
-
0.27%
Other operating expenses
-
-
-
-
Net income
-370.00K
-
2.20M
3.33M
Net profit margin
-10.41%
-
59.24%
62.60%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
6.00K
Interest expense
-1.00K
-
-6.00K
-
Net interest expenses
-1.00K
-
-6.00K
6.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-940.50K
-
54.75K
1.54M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps